DE69414115D1 - Vitamin d analoge - Google Patents

Vitamin d analoge

Info

Publication number
DE69414115D1
DE69414115D1 DE69414115T DE69414115T DE69414115D1 DE 69414115 D1 DE69414115 D1 DE 69414115D1 DE 69414115 T DE69414115 T DE 69414115T DE 69414115 T DE69414115 T DE 69414115T DE 69414115 D1 DE69414115 D1 DE 69414115D1
Authority
DE
Germany
Prior art keywords
alpha
vitamin
azide
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69414115T
Other languages
English (en)
Other versions
DE69414115T2 (de
Inventor
Robert Hesse
Malathi Ramgopal
Gaddam Reddy
Sundara Setty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Medicine and Chemistry Inc
Original Assignee
Research Institute for Medicine and Chemistry Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Medicine and Chemistry Inc filed Critical Research Institute for Medicine and Chemistry Inc
Application granted granted Critical
Publication of DE69414115D1 publication Critical patent/DE69414115D1/de
Publication of DE69414115T2 publication Critical patent/DE69414115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69414115T 1993-07-23 1994-07-22 Vitamin d analoge Expired - Fee Related DE69414115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939315253A GB9315253D0 (en) 1993-07-23 1993-07-23 Chemical compounds
PCT/GB1994/001587 WO1995003273A1 (en) 1993-07-23 1994-07-22 Vitamin d analogues

Publications (2)

Publication Number Publication Date
DE69414115D1 true DE69414115D1 (de) 1998-11-26
DE69414115T2 DE69414115T2 (de) 1999-04-08

Family

ID=10739292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69414115T Expired - Fee Related DE69414115T2 (de) 1993-07-23 1994-07-22 Vitamin d analoge

Country Status (20)

Country Link
US (2) US5872140A (de)
EP (1) EP0710227B1 (de)
JP (1) JPH09500637A (de)
KR (1) KR100321415B1 (de)
CN (1) CN1043883C (de)
AT (1) ATE172451T1 (de)
AU (1) AU690565B2 (de)
CA (1) CA2167837A1 (de)
CZ (1) CZ20796A3 (de)
DE (1) DE69414115T2 (de)
DK (1) DK0710227T3 (de)
ES (1) ES2125466T3 (de)
FI (1) FI113535B (de)
GB (1) GB9315253D0 (de)
HU (1) HU221597B (de)
IL (1) IL110415A (de)
NO (1) NO314453B1 (de)
NZ (1) NZ268659A (de)
WO (1) WO1995003273A1 (de)
ZA (1) ZA945427B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
CA2385755C (en) 1999-09-29 2007-02-06 Colotech A/S Prevention of colorectal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
AU2003283101B2 (en) * 2002-11-04 2008-12-11 Dsm Nutritional Products Ag Microcapsules having multiple shells and method for the preparation thereof
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
CA2596023A1 (en) * 2005-01-27 2006-11-09 Ocean Nutrition Canada Ltd. Fatty acid-benzenediol derivatives and methods of making and using thereof
CA2556520C (en) * 2005-01-27 2008-10-28 Ocean Nutrition Canada Ltd. Chromium-fatty acid compounds and methods of making and using thereof
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
EP2007224A2 (de) * 2006-04-07 2008-12-31 Ocean Nutrition Canada Limited Emulsionen und mikrokapseln mit stoffen mit geringer grenzflächenspannung, herstellungsverfahren und verwendung
MX306461B (es) * 2006-06-05 2013-01-07 Ocean Nutrition Canada Ltd Microcapsulas con cubiertas mejoradas
KR101454942B1 (ko) 2007-01-10 2014-10-27 디에스엠 뉴트리셔널 프라덕츠 아게 채식주의용 마이크로캡슐
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
WO2010088304A1 (en) 2009-01-27 2010-08-05 Cytotech Labs, Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
KR101880032B1 (ko) 2009-08-14 2018-07-20 베르그 엘엘씨 탈모증 치료용 비타민 ｄ3 및 이의 유사체들
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN104926739B (zh) * 2015-06-09 2017-06-27 南京理工大学 基于氮杂环修饰的维生素d2衍生物、合成及应用
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114570B (en) * 1981-11-02 1985-08-07 Res Inst Medicine Chem Chemical compounds
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
US5446635A (en) * 1993-06-24 1995-08-29 Quarton, Inc. Laser assembly for marking a line on a workpiece for guiding a cutting tool

Also Published As

Publication number Publication date
IL110415A0 (en) 1996-03-31
DK0710227T3 (da) 1999-06-28
DE69414115T2 (de) 1999-04-08
FI113535B (fi) 2004-05-14
JPH09500637A (ja) 1997-01-21
US5872140A (en) 1999-02-16
WO1995003273A1 (en) 1995-02-02
CA2167837A1 (en) 1995-02-02
CZ20796A3 (en) 1996-10-16
CN1043883C (zh) 1999-06-30
NO314453B1 (no) 2003-03-24
EP0710227B1 (de) 1998-10-21
NO960251L (no) 1996-03-22
HU9600136D0 (en) 1996-03-28
IL110415A (en) 2000-01-31
FI960303L (fi) 1996-03-22
FI960303A0 (fi) 1996-01-22
HUT73846A (en) 1996-09-30
ZA945427B (en) 1995-08-24
CN1129441A (zh) 1996-08-21
US6013814A (en) 2000-01-11
EP0710227A1 (de) 1996-05-08
GB9315253D0 (en) 1993-09-08
ES2125466T3 (es) 1999-03-01
AU7193994A (en) 1995-02-20
ATE172451T1 (de) 1998-11-15
HU221597B (hu) 2002-11-28
NO960251D0 (no) 1996-01-22
KR100321415B1 (ko) 2002-11-13
AU690565B2 (en) 1998-04-30
NZ268659A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
DE69414115D1 (de) Vitamin d analoge
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
IL74497A0 (en) Pharmaceutical compositions and phenyl carbamate derivatives
EP0172458A3 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
MY132115A (en) Novel thrombin inhibitors
ATE133181T1 (de) Dehydrodidemnin b
DE69412476D1 (de) Vitamin-d-amid-derivate
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
ES2010853A6 (es) Composiciones de tensoactivos sinergicos.
NO981393D0 (no) Guanidinoproteasehemmere
FI963754A0 (fi) D-vitamiinijohdannaisia
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
MX9803901A (es) Compuestos de di-terbutilfenol que contienen azufre utiles como agentes anti-inflamatorios.
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
AU6722498A (en) Disubstituted biphenyloxazolines
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
BR9407232A (pt) Compostos de tiocarbamoíla
YU23498A (sh) Herbicidni 3,5-difluoropiridini
ITMI931808A1 (it) Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico
SU1783778A1 (ru) Производные 4-(1-окси-1-аминокарбонил-2,2,2-трифторэтил)-n-этиланилинов, обладающие антидотной активностью к хлорсульфурону

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee